Mallinckrodt Pharmaceuticals Donates Drug Deactivation Pouches to Enable Safe Disposal of Prescription Drugs in Kentucky
Mallinckrodt Pharmaceuticals | October 20, 2016
Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, today announced it will provide 160,000 drug deactivation pouches to families in Kentucky as well as across the U.S. Midwest and Central Appalachia to encourage the safe and responsible disposal of leftover prescription pain medications.